1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Adjuvant imatinib for GIST : duration likely matters (
- 2018
- The management and survival outcomes of nasopharyngeal cancer in the Nordic countries* (
- Bone sarcomas : ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (
- Gastrointestinal stromal tumours : ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (
- 2012
- Adjuvant therapy in primary GIST: state-of-the-art (
- 2005
- Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells (
- 2004
- Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel (